Every trade Kim Schrier (U.S. House, Washington’s 8th district) disclosed under the STOCK Act: what was bought and sold, how the stock purchases did against the S&P 500 and how long each disclosure took. Data as of Oct 20, 2026.
Kim Schrier (U.S. House, Washington’s 8th district) disclosed 36 trades between Mar 22, 2019 and Mar 22, 2022 in STOCK Act periodic transaction reports, 36 of them in individual stocks: 2 purchases and 34 sales. Their estimated volume is $12.0 million, from the midpoints of the disclosed ranges. By account owner: self or joint 92%, spouse 8% of the trades.
| Measure | Kim Schrier |
|---|---|
| Chamber | U.S. House, Washington’s 8th district |
| Trades disclosed | 36 |
| Stock trades | 36 (2 buys, 34 sales) |
| First and latest trade | Mar 22, 2019 – Mar 22, 2022 |
| Estimated volume | $12.0 million |
| Account owner | Self or joint 92% · Spouse 8% |
| Stock | Company | Trades |
|---|---|---|
| AAPL | Apple Inc. | 16 |
| TSLA | Tesla, Inc. | 4 |
| PYPL | PayPal Holdings, Inc. | 1 |
| CVS | CVS Health Corporation | 1 |
| GOOGL | Alphabet Inc. | 1 |
| LOW | Lowe's Companies, Inc. | 1 |
| EWBC | East West Bancorp, Inc. | 1 |
| CLF | Cleveland-Cliffs Inc. | 1 |
| HON | Honeywell International Inc. | 1 |
| IBM | International Business Machines Corporation | 1 |
By sector: Technology (18), Consumer Cyclical (5), Financial Services (3), Healthcare (3), Industrials (3), Communication Services (2). Counts of disclosed trades in each stock, buys and sales together, before the last 30 days.
Exent scored 2 disclosed stock purchases by Kim Schrier against the S&P 500. Over the 12 months after each trade they beat the S&P 500 by an average of 15.6 percentage points, and 100.0% of the 2 purchases that are a year old beat the index. Measured from the disclosure date, the first day the public could see each trade, the 12‑month figure was +12.2%. Kim Schrier is not ranked: the ranking needs at least 20 purchases that are a year old.
| Measure | Kim Schrier | All members |
|---|---|---|
| Stock buys scored | 2 | 24,613 |
| Average vs S&P 500, 3 months | +3.9% | −0.1% |
| Average vs S&P 500, 12 months | +15.6% | −0.4% |
| Buys that beat it over 12 months | 100.0% | 43.2% |
| 12 months from the disclosure date | +12.2% | −0.8% |
| Rank | Not ranked | — |
The 10 members with the best records by this measure are named in Exent Radar, with their latest trades.
1 of Kim Schrier’s 36 disclosed trades (2.8%) were reported more than 45 days after the trade, the STOCK Act deadline. The median trade was disclosed 21 days after it was made; the longest delay was 108 days.
| Measure | Kim Schrier | All members |
|---|---|---|
| Median days to disclose | 21 days | 28 days |
| Disclosed after 45 days | 2.8% | 14.9% |
| Longest delay | 108 days | — |
Trades disclosed before Sep 20, 2026 are listed below, newest first, each with a link to the original filing.
| Trade date | Stock | Trade | Amount | Disclosed after |
|---|---|---|---|---|
| Mar 22, 2022 | AAPL | Sale (joint) | $500,001–$1,000,000 | 30 days · filing |
| Mar 22, 2022 | AAPL | Sale (joint) | $250,001–$500,000 | 30 days · filing |
| Mar 22, 2022 | TSLA | Sale (joint) | $250,001–$500,000 | 30 days · filing |
| Mar 22, 2022 | TSLA | Sale (spouse) | $250,001–$500,000 | 30 days · filing |
| Nov 15, 2021 | AAPL | Sale (joint) | $250,001–$500,000 | 22 days · filing |
| Oct 28, 2021 | PYPL | Sale (joint) | $1,001–$15,000 | 21 days · filing |
| Oct 28, 2021 | CVS | Sale (joint) | $15,001–$50,000 | 21 days · filing |
| Oct 28, 2021 | GOOGL | Sale (joint) | $15,001–$50,000 | 21 days · filing |
| Oct 28, 2021 | LOW | Sale (joint) | $15,001–$50,000 | 21 days · filing |
| Oct 28, 2021 | EWBC | Sale (joint) | $15,001–$50,000 | 21 days · filing |
| Oct 28, 2021 | CLF | Sale (joint) | $15,001–$50,000 | 21 days · filing |
| Oct 28, 2021 | HON | Sale (joint) | $1,001–$15,000 | 21 days · filing |
| Oct 28, 2021 | IBM | Sale (joint) | $1,001–$15,000 | 21 days · filing |
| Oct 28, 2021 | JPM | Sale (joint) | $15,001–$50,000 | 21 days · filing |
| Oct 28, 2021 | J | Sale (joint) | $15,001–$50,000 | 21 days · filing |
| Oct 28, 2021 | AAPL | Buy (joint) | $250,001–$500,000 | 21 days · filing |
| Oct 28, 2021 | CSCO | Sale (joint) | $15,001–$50,000 | 21 days · filing |
| Oct 28, 2021 | DCI | Sale (joint) | $1,001–$15,000 | 21 days · filing |
| Oct 28, 2021 | BMY | Sale (joint) | $1,001–$15,000 | 21 days · filing |
| Oct 28, 2021 | ABT | Sale (joint) | $1,001–$15,000 | 21 days · filing |
| Oct 28, 2021 | COST | Sale (joint) | $15,001–$50,000 | 21 days · filing |
| Oct 28, 2021 | LUMN | Sale (joint) | $1,001–$15,000 | 21 days · filing |
| Jul 27, 2021 | AAPL | Buy (joint) | $500,001–$1,000,000 | 108 days · filing |
| Mar 3, 2020 | AAPL | Sale (joint) | $250,001–$500,000 | 5 days · filing |
| Mar 3, 2020 | AAPL | Sale (spouse) | $250,001–$500,000 | 5 days · filing |
| Trade date | Stock | Trade | Amount | Disclosed after |
|---|---|---|---|---|
| Mar 3, 2020 | AAPL | Sale (joint) | $1,000,001–$5,000,000 | 5 days · filing |
| Mar 3, 2020 | TSLA | Sale (joint) | $100,001–$250,000 | 5 days · filing |
| Mar 3, 2020 | TSLA | Sale (spouse) | $100,001–$250,000 | 5 days · filing |
| Mar 2, 2020 | AAPL | Sale (joint) | $250,001–$500,000 | 6 days · filing |
| Mar 2, 2020 | AAPL | Sale (joint) | $1,000,001–$5,000,000 | 6 days · filing |
| Feb 28, 2020 | AAPL | Sale (joint) | $100,001–$250,000 | 9 days · filing |
| Feb 28, 2020 | AAPL | Sale (joint) | $250,001–$500,000 | 9 days · filing |
| Jan 29, 2020 | AAPL | Sale (joint) | $50,001–$100,000 | 0 days · filing |
| Oct 21, 2019 | AAPL | Sale (joint) | $50,001–$100,000 | 0 days · filing |
| Sep 12, 2019 | AAPL | Sale (joint) | $50,001–$100,000 | 20 days · filing |
| Mar 22, 2019 | AAPL | Sale (joint) | $50,001–$100,000 | 39 days · filing |
Members of Congress report each trade over $1,000 in stocks, bonds and other securities, by themselves, their spouse or dependent children, in periodic transaction reports under the STOCK Act, filed with the House Clerk and the Senate. A trade must be reported within 45 days. Exent reads these public financial disclosures; every trade listed here links to its original filing.
Amounts are disclosed as ranges ($1,001–$15,000, $15,001–$50,000 and up), so dollar volumes are estimates from the midpoint of each range. Returns compare each disclosed purchase of a listed stock with the S&P 500 (SPY): total return with dividends from the close on the trade date to 3 and 12 months later, and again from the disclosure date, the first day the public could see the trade. Sales are not scored. The ranking covers members with at least 20 purchases that are a year old.
Trades disclosed in the last 30 days are counted but not listed; they are in Exent Radar, with the records of the top 10 performers. The disclosures carry no party labels: this is the public record of what was traded and when it was disclosed. Data as of Oct 20, 2026. How to read a filing yourself: Congress stock trading: how to see what members bought.
Past performance does not guarantee future results. Historical figures are calculated by Exent from market data and are for education only; they are not investment advice or a recommendation to buy or sell any security.
In STOCK Act disclosures, the stocks Kim Schrier traded most often are AAPL (16 trades), TSLA (4 trades), PYPL (1 trade), CVS (1 trade), GOOGL (1 trade). Of 36 disclosed trades, 36 were in individual stocks. Periodic transaction reports show trades, not full holdings.
Kim Schrier's disclosed stock purchases beat the S&P 500 by an average of 15.6 percentage points over the 12 months after each trade (2 purchases a year old), and 100.0% of them beat the index. Measured from the disclosure date the average was +12.2%. Past results do not predict future ones.
1 of 36 disclosed trades (2.8%) were reported after the STOCK Act's 45-day deadline. The median trade was disclosed 21 days after it was made, the longest 108 days; across Congress the median is 28 days.
Exent Radar shows trades by members of Congress, company insiders and big funds as they are disclosed, with the records of the top performers.
Educational content, not investment advice. Examples are illustrative; past performance does not guarantee future results.